Last filing: Jun 25, 2026. Most recent sale before this period: May 15, 2024.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- Last sale before this period: May 15, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. (RYTM) | Director | Aug 1, 2019 | Jun 25, 2026 |
| Alnylam Pharmaceuticals, Inc. (ALNY) | Director | Jan 7, 2026 | May 22, 2026 |
| Vertex Pharmaceuticals (VRTX) | EVP, COO | Sep 6, 2012 | Jul 2, 2025 |
Also a director at
Recent filings
The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.